Skip to content

Companies Investors Funds People Markets

/

Loading company…

Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

© 2026 CapbaseData CC BY-NC 4.0 · Code AGPL-3.0support@capbase.fyi

Immorta Bio, Inc. — Funding, Investors & Profile — Capbase

← All companies

I

Immorta Bio, Inc.

Private

Private securities offering disclosed via SEC Form D.

Biotechnology

SEC CIK: 0002102665

Founded: 2023Source: [SEC]
Headquarters: MIAMI BEACH, FLORIDASource: [SEC]
Country: United StatesSource: [SEC]
Headcount: —Source: [SEC]
Stage

$612.5KSource: [SEC]Raised (recorded)

UndisclosedSource: [SEC]Last valuation

Overview

Immorta Bio, Inc. filed a Form D notice of exempt offering with the SEC.

Funding rounds

1 round

1 round recorded · latest Private placement (Form D), Nov 2024 · $612.5K recorded

Sign in to see 1 rounds.

Investors

No investors recorded yet for Immorta Bio, Inc..

Add an investor

People

Leadership

Boris ReznikExecutive OfficerSince 2026Source: [SEC]

Acquisitions

Immorta Bio, Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Diversity investments

No diversity signals recorded yet for Immorta Bio, Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Seed

Sector

Healthcare